Multinormal In Vitro Distribution Model Suitable for the Distribution ofPlasmodium falciparumChemosusceptibility to Doxycycline
- 1 February 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (2) , 688-695
- https://doi.org/10.1128/aac.00546-08
Abstract
The distribution and range of 50% inhibitory concentrations (IC50s) of doxycycline were determined for 747 isolates obtained between 1997 and 2006 from patients living in Senegal, Republic of the Congo, and Gabon and patients hospitalized in France for imported malaria. The statistical analysis was designed to answer the specific question of whetherPlasmodium falciparumhas different phenotypes of susceptibility to doxycycline. A triple normal distribution was fitted to the data using a Bayesian mixture modeling approach. The IC50geometric mean ranged from 6.2 μM to 11.1 μM according to the geographical origin, with a mean of 9.3 μM for all 747 parasites. The values for all 747 isolates were classified into three components: component A, with an IC50mean of 4.9 μM (±2.1 μM [standard deviation]); component B, with an IC50mean of 7.7 μM (±1.2 μM); and component C, with an IC50mean of 17.9 μM (±1.4 μM). According to the origin of theP. falciparumisolates, the triple normal distribution was found in each subgroup. However, the proportion of isolates predicted to belong to component B was most important in isolates from Gabon and Congo and in isolates imported from Africa (from 46 to 56%). In Senegal, 55% of theP. falciparumisolates were predicted to be classified as component C. The cutoff of reduced susceptibility to doxycycline in vitro was estimated to be 35 μM.Keywords
This publication has 54 references indexed in Scilit:
- In Vitro Monitoring of Plasmodium falciparum Drug Resistance in French Guiana: a Synopsis of Continuous Assessment from 1994 to 2005Antimicrobial Agents and Chemotherapy, 2008
- Multiple Antibiotics Exert Delayed Effects against the Plasmodium falciparum ApicoplastAntimicrobial Agents and Chemotherapy, 2007
- World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malariaMalaria Journal, 2007
- World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibilityMalaria Journal, 2007
- The rationale and plan for creating a World Antimalarial Resistance Network (WARN)Malaria Journal, 2007
- Rapid Dissemination of Plasmodium falciparum Drug Resistance Despite Strictly Controlled Antimalarial UsePLOS ONE, 2007
- Tetracyclines Specifically Target the Apicoplast of the Malaria Parasite Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2006
- Prevalence of In Vitro Resistance to Eleven Standard or New Antimalarial Drugs among Plasmodium falciparum Isolates from Pointe-Noire, Republic of the CongoJournal of Clinical Microbiology, 2006
- Functional, Biophysical, and Structural Bases for Antibacterial Activity of TigecyclineAntimicrobial Agents and Chemotherapy, 2006